Status | Study |
Terminated |
Study Name: Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Condition: Nystagmus, Congenital Nystagmus, Acquired Date: 2008-11-27 Interventions: Drug: Neramexane mesylate open-label treatment of 36 months Neramexane mesylate up to 75 mg per day |
Completed |
Study Name: Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus Condition: Nystagmus, Congenital Idiopathic Nystagmus, Acquired Date: 2008-04-15 Interventions: Drug: Neramexane mesylate 2 double-blind, cross-over treatment periods of 7 weeks separated by a wash-ou |
Completed |
Study Name: Eye Muscle Surgery to Treat Congenital Nystagmus Condition: Nystagmus Date: 1999-11-03 Interventions: Procedure: horizontal muscles of the eye will be cut and then reattached in the same position |